GT Biopharma, Inc. (GTBP)
0.677
0.00 (0.00%)
USD |
NASDAQ |
Jan 09, 16:00
0.67
-0.01
(-1.03%)
After-Hours: 20:00
GT Biopharma Research and Development Expense (Quarterly): 0.634M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| SELLAS Life Sciences Group, Inc. | 4.216M |
| Lyell Immunopharma, Inc. | 25.61M |
| Plus Therapeutics, Inc. | 2.436M |
| Geron Corp. | 21.07M |